Macquarie Group LTD Novartis Ag Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Novartis Ag stock. As of the latest transaction made, Macquarie Group LTD holds 141,577 shares of NVS stock, worth $16.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

141,577

Previous 381,786 62.92%

Holding current value

$16.4 Million

Previous $36.9 Million 59.19%

% of portfolio

0.02%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$92.57 - $107.37 $22.2 Million - $25.8 Million	-240,209 Reduced 62.92%	141,577 $15.1 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $4.98 Million - $5.67 Million	-52,289 Reduced 12.05%	381,786 $36.9 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $19.8 Million - $21.8 Million	-214,378 Reduced 33.06%	434,075 $43.8 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $1.12 Million - $1.24 Million	-11,828 Reduced 1.79%	648,453 $66.1 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $1.21 Million - $1.37 Million	-13,046 Reduced 1.94%	660,281 $66.6 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $1.03 Million - $1.19 Million	-12,839 Reduced 1.87%	673,327 $61.9 Million
Q4 2022 Feb 21, 2023	SELL	$75.55 - $92.52 $8.65 Million - $10.6 Million	-114,468 Reduced 14.3%	686,166 $62.2 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $1.27 Million - $1.48 Million	-17,012 Reduced 2.08%	800,634 $60.9 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $1.46 Million - $1.7 Million	-18,139 Reduced 2.17%	817,646 $69.1 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $2.36 Million - $2.67 Million	29,415 Added 3.65%	835,785 $73.3 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $2.19 Million - $2.43 Million	27,520 Added 3.53%	806,370 $70.5 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $447,990 - $521,176	-5,478 Reduced 0.7%	778,850 $63.7 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $5.72 Million - $6.32 Million	67,092 Added 9.35%	784,328 $71.6 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $9.29 Million - $11 Million	111,204 Added 18.35%	717,236 $61.3 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $1.9 Million - $2.29 Million	-24,286 Reduced 3.85%	606,032 $57.2 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $2.89 Million - $3.2 Million	-35,156 Reduced 5.28%	630,318 $54.8 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $13.7 Million - $15.4 Million	-169,360 Reduced 20.29%	665,474 $58.1 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $2.38 Million - $3.34 Million	-33,699 Reduced 3.88%	834,834 $68.8 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $686,862 - $776,597	-8,143 Reduced 0.93%	868,533 $82.2 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $2.09 Million - $2.31 Million	-24,463 Reduced 2.71%	876,676 $76.2 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $728,288 - $896,355	-9,659 Reduced 1.06%	901,139 $82.3 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $996,784 - $1.14 Million	-13,234 Reduced 1.43%	910,798 $87.6 Million
Q4 2018 Feb 15, 2019	SELL	$73.66 - $82.02 $615,429 - $685,277	-8,355 Reduced 0.9%	924,032 $79.3 Million
Q3 2018 Nov 15, 2018	SELL	$66.94 - $77.43 $2.31 Million - $2.68 Million	-34,550 Reduced 3.57%	932,387 $80.3 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $628,328 - $710,124	-9,680 Reduced 0.99%	966,937 $73 Million
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $12.2 Million - $14.6 Million	-173,595 Reduced 15.09%	976,617 $79 Million
Q4 2017 Feb 15, 2018	SELL	$72.33 - $77.64 $1.05 Million - $1.12 Million	-14,480 Reduced 1.24%	1,150,212 $96.6 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $86.4 Million - $90 Million	1,164,692	1,164,692 $100 Million

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Novartis Ag Transaction History